EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS

被引：0
|
作者：
Kamiya, M. [1 ]
Mori, S. [1 ]
Yamazaki, K. [1 ]
Togawa, D. [1 ]
机构：
[1] Kindai Univ, Nara Hosp, Dept Orthopaed & Rheumatol, Ikoma, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.650
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0670
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [21] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 643 - 644
  • [22] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] Treating active rheumatoid arthritis with Janus kinase inhibitors
    Scott, David L.
    Stevenson, Matt D.
    LANCET, 2017, 390 (10093): : 431 - 432
  • [24] Developments with investigational Janus kinase inhibitors for rheumatoid arthritis
    Semerano, Luca
    Decker, Patrice
    Clavel, Gaelle
    Boissier, Marie-Christophe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (12) : 1355 - 1359
  • [25] Role of Janus Kinase inhibitors in rheumatoid arthritis treatment
    Reddy, Virginia
    Cohen, Stanley
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 300 - 306
  • [26] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 Weeks
    Genovese, Mark
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks
    Smolen, Josef
    Emery, Paul
    Rigby, William
    Tanaka, Yoshiya
    Vargas, Juan
    Damjanov, Nemanja
    Jain, Manish
    Song, Yanna
    Khan, Nasser
    Enejosa, Jeffrey
    Cohen, Stanley
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
    Youssef, Peter
    Ciciriello, Sabina
    Tahir, Talib
    Leadbetter, Joanna
    Butcher, Belinda
    Calao, Miriam
    Walsh, Nicole
    O'Sullivan, Catherine
    Smith, Tegan
    Littlejohn, Geoffrey
    RHEUMATOLOGY AND THERAPY, 2025, 12 (01) : 173 - 202
  • [29] Prescribing pattern of Janus kinase inhibitors drugs in rheumatoid arthritis patients in Taiwan
    Hsu, Hsing-Yu
    Lee, Yi-Hui
    Huang, Ching-Ya
    Hsieh, Yow-Wen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 271 - 271
  • [30] Effect of different Janus Kinase Inhibitors on synovial Fibroblasts of Patients with Rheumatoid Arthritis
    Diller, Magnus
    Huelser, Marie-Lisa
    Rehart, Stefan
    Fleck, Martin
    Neumann, Elena
    Mueller-Ladner, Ulf
    INTERNIST, 2018, 59 : S7 - S8
12345